Market Overview

Why Adamas Pharmaceuticals Is Trading Lower Today

Why Adamas Pharmaceuticals Is Trading Lower Today

Adamas Pharmaceuticals (NASDAQ: ADMS) shares are trading lower on Thursday after the company reconfirmed it will not initiate further Phase 3 development in MSW.

Adamas Pharmaceuticalsdiscovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease.

It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Adamas Pharmaceuticals shares were trading down 3.8% at $2.75 at time of publication on Thursday. The stock has a 52-week high of $7.78 and a 52-week low of $1.90.


Related Articles (ADMS)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Health Care General